US Edition
News from oncnursingnews.com
Top oncnursingnews.com News
United States · United StatesZydus Lifesciences Ltd has been tentatively approved by the USFDA for its generic Ibrutinib tablets. These tablets, used to treat blood cancers, will be manufactured in Ahmedabad. According to IQVIA data, the Ibrutinib market generated USD 2.15 billion in the US in 2025.See the Story
Zydus Lifesciences Secures Tentative FDA Nod for Generic Cancer Drug
100% Center coverage: 2 sources
MedicalResearchers at Uppsala University have identified a promising therapeutic approach for the challenging blood cancer multiple myeloma. In a new preclinical study, they demonstrate that a dual treatment with drugs that inhibit epigenetic regulation reduces tumor growth and induces cancer cell death. The findings are published in the journal Blood Advances.See the Story
Drug Combination Shows Promising Anti-Tumor Effects on Blood Cancer Cells
100% Center coverage: 1 sources
Canada · CanadaPanelists discuss how a 48-year-old fitness instructor with ALK-rearranged stage IV lung cancer and bone metastases was successfully treated with alectinib, experiencing manageable adverse effects while returning to modified teaching activities.See the Story
